(Part 1) Multi-stakeholder Hearing on Antimicrobial…

• Opening Segment

• Panel 1: Adequate, predictable, and sustainable financing of and investments in the AMR response to support country-level implementation.

• Panel 2: Addressing antimicrobial access, research and development (R&D), and innovation.

Participants will exchange views on key priorities for the high-level meeting and its political declaration, while exploring key challenges and potential solutions needed for effectively addressing AMR at the national, regional and global levels.

While some progress has been achieved over the past years, AMR remains a significant health and developmental challenge, being listed as one of the top 10 global public health threats facing humanity. It contributes to 5 million deaths per year, 1 million of which are among children under five years of age. Limiting the emergence and spread of drug-resistant pathogens and sustaining the effectiveness of antimicrobials is critical to preserving the world's ability to treat diseases in humans, animals, and plants, reduce food safety and food security risks, promote economic development and equity within societies, protect the environment and maintain progress towards the Sustainable Development Goals.